Bank of America
CRDL

Bank of America’s Cardiol Therapeutics CRDL Stock Holding History

Bank of America’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-367,453
Closed -$350K – 5976
2025
Q4 		$350K Sell
367,453
-183,600
-33% -$192K ﹤0.01% 5099
2025
Q3 		$590K Buy
551,053
+524,598
+1,983% +$637K ﹤0.01% 5685
2025
Q2 		$36K Buy
26,455
+15,255
+136% +$17.8K ﹤0.01% 6909
2025
Q1 		$10.9K Sell
11,200
-300
-3% -$368 ﹤0.01% 7098
2024
Q4 		$14.7K Buy
11,500
+7,500
+188% +$12.6K ﹤0.01% 6906
2024
Q3 		$7.92K Hold
4,000
– – ﹤0.01% 6928
2024
Q2 		$8.08K Hold
4,000
– – ﹤0.01% 6926
2024
Q1 		$7.24K Hold
4,000
– – ﹤0.01% 6947
2023
Q4 		$3.37K Hold
4,000
– – ﹤0.01% 7067
2023
Q3 		$3.58K Buy
+4,000
New +$3.82K ﹤0.01% 7062
2023
Q2 		– Sell
-60,500
Closed -$29.5K – 7740
2023
Q1 		$29.5K Buy
+60,500
New +$35.8K ﹤0.01% 6646
2022
Q4 		– Sell
-1,399
Closed -$1K – 8243
2022
Q3 		$1K Sell
1,399
-17,714
-93% -$21.6K ﹤0.01% 7656
2022
Q2 		$25K Buy
+19,113
New +$27.2K ﹤0.01% 7108
2022
Q1 		– Sell
-1,300
Closed -$2K – 8326
2021
Q4 		$2K Sell
1,300
-12,508
-91% -$34.5K ﹤0.01% 7980
2021
Q3 		$57K Buy
+13,808
New +$50K ﹤0.01% 6985

Other funds holding CRDL

MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
IA
Integrity Alliance Urbandale, Iowa $2.64B AUM 16.75% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America's CRDL Position: Q1 2026 in Review

Bank of America sold out of Cardiol Therapeutics (CRDL) in Q1 2026, closing a stake of 367,453 shares — an estimated $350K sold.

Bank of America first reported a position in CRDL in Q3 2021 and held it in 15 quarters. The position peaked at $590K in Q3 2025. 47 funds tracked by Wall St. Rank hold CRDL as of Q1 2026.

  • Bank of America reported no remaining Cardiol Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 367,453 Cardiol Therapeutics shares in Q1 2026, an estimated $350K.
  • Bank of America first reported a position in Cardiol Therapeutics in Q3 2021 and held it in 15 quarters.
  • Bank of America's Cardiol Therapeutics position peaked at $590K in Q3 2025.
  • 47 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.